Clinical Trial Update: Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating risk-adapted treatment for primary acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias | Conditions: Leukemia, Myelocytic, Acute | Phase 2 | Status: COMPLETED